Skip to main content

Table 2 Human cell lines utilized for the present study

From: Development of aqueous-based multi-herbal combination using principal component analysis and its functional significance in HepG2 cells

S. No. Cells Tissue origin Malignancy Cell doubling time
1. A-549 Lung Carcinoma ~ 22 h
2. HeLa Cervix Adenocarcinoma ~ 25 h
3. IMR-32 Sympathetic nervous system Neuroblastoma ~ 20 h
4. HepG2 Liver Hepatocellular carcinoma ~ 48 h
5. MG-63 Bone Osteosarcoma ~ 28 h
6. 293 T Embryonic kidney Non-malignant ~ 27 h